Comorbid ADHD and schizophrenia and the use of psychostimulants: a scoping review protocol
Introduction Schizophrenia and attention deficit hyperactivity disorder (ADHD) are psychiatric disorders that have a profound impact on patients and healthcare systems globally. There is preliminary evidence suggesting a potential association between the two in terms of symptomatology and genetic un...
        Saved in:
      
    
          | Main Authors: | Nusrat Husain, Ariana Axiaq, Steven Marwaha, Jordan Bamford, I Qurashi | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | 
            BMJ Publishing Group
    
        2024-10-01
     | 
| Series: | BMJ Open | 
| Online Access: | https://bmjopen.bmj.com/content/14/10/e090290.full | 
| Tags: | 
       Add Tag    
     
      No Tags, Be the first to tag this record!
   
 | 
Similar Items
- 
                
                    Physical comorbidity and use of healthcare services in people with schizophrenia: protocol for a systematic review        
                          
by: Enrique Baca-Garcia, et al.
Published: (2021-12-01) - 
                
                    Impact of psychostimulants on microbiota and short-chain fatty acids alterations in children with attention-deficit/hyperactivity disorder        
                          
by: Nonglak Boonchooduang, et al.
Published: (2025-01-01) - 
                
                    Psychosocial functioning of adolescents with ADHD in the family, school and peer group: A scoping review protocol.        
                          
by: Kinga Karteczka-Świętek, et al.
Published: (2022-01-01) - 
                
                    Somatic comorbidities and health related uncertainty among Swedish adolescents with ADHD        
                          
by: Sara Lundqvist, et al.
Published: (2025-02-01) - 
                
                    Digital assessments for children and adolescents with ADHD: a scoping review        
                          
by: Franceli L. Cibrian, et al.
Published: (2024-10-01)